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Gustav Torisson1*, Lennart Minthon1, Lars Stavenow2 and Elisabet Londos1Abstract
Background: Detecting cognitive impairment in medical inpatients is important due to its association with adverse
outcomes. Our aim was to study recognition of cognitive impairment and its association with mortality.
Methods: 200 inpatients aged over 60 years were recruited at the Department of General Internal Medicine at
University Hospital MAS in Malmö, Sweden. The MMSE (Mini-Mental State Examination) and the CDT (Clock-
Drawing Test) were performed and related to recognition rates by patients, staff physicians, nurses and informants.
The impact of abnormal cognitive test results on mortality was studied using a multivariable Cox proportional
hazards regression.
Results: 55 patients (28%) had no cognitive impairment while 68 patients (34%) had 1 abnormal test result
(on MMSE or CDT) and 77 patients (39%) had 2 abnormal test results. Recognition by healthcare professionals
was 12% in the group with 1 abnormal test and 44-64% in the group with 2 abnormal test results. In our model,
cognitive impairment predicted 12-month mortality with a hazard ratio (95% CI) of 2.86 (1.28-6.39) for the group
with 1 abnormal cognitive test and 3.39 (1.54-7.45) for the group with 2 abnormal test results.
Conclusions: Cognitive impairment is frequent in medical inpatients and associated with increased mortality.
Recognition rates of cognitive impairment need to be improved in hospitals.
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Recognising cognitive impairment is of growing import-
ance, as the worldwide prevalence of dementia is increas-
ing [1]. In elderly medical inpatients this is particularly
important, as cognitive impairment is a poor prognostic
factor and an independent predictor of mortality [2-4].
Furthermore, cognitive impairment may be associated
with undetected medical comorbidities, mental incapacity
and risk of accidents at home after discharge [5-8]. In hos-
pitals, patients with cognitive impairment may have com-
munication difficulties when specifying their complaints
or in the comprehension of discharge information [9].
Cognitive impairment is often undetected during an ad-
mission in general hospital settings [10-14]. In primary
care, cognitive impairment is often underdiagnosed as well* Correspondence: gustav.torisson@med.lu.se
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reproduction in any medium, provided the or[15-19]. This has highlighted the need for cognitive
screening to improve detection. In community-based stud-
ies, screening with subjective memory complaints (SMCs)
have been tried with varying results, possibly due to large
inconsistencies in definition of SMCs [20,21]. In hospital
settings, delirium guidelines have recommended screening
by performing cognitive tests on all elderly patients admit-
ted to hospital [22]. Our aim was to assess the need for
such a screening by performing cognitive tests in a general
hospital population and compare the results with SMCs
and recognition from healthcare professionals. To deter-
mine the risk accompanying cognitive impairment we also
aimed to study its association with mortality.Methods
Setting
The study was carried out at the wards of the Depart-
ment of General Internal Medicine at the Universityl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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from October 2009 through June 2010. At the time, the
hospital was a 700-bed teaching hospital, providing
healthcare to the community of Malmö and its sur-
rounding areas. The hospital is now part of the larger
Skåne University Hospital.
The Department of General Internal Medicine con-
sisted of four wards with a similar general medical pro-
file. The average length of stay was 6.4 days. Most
patients (90-95%) were admitted through the hospital’s
Emergency Department (ED), the rest were directly
referred via their GPs.
The study included only the hospital’s general internal
medicine wards; all medical departments with a higher
degree of specialisation (Endocrinology, Angiology,
Haematology, Nephrology, Gastroenterology, Rheuma-
tology, Cardiology, the Department of Infectious Dis-
eases and the Department of Pulmonary Diseases) were
excluded. At the general internal medicine wards,
patients tended to be older or to have multiple comor-
bidities to a larger extent than at the more specialised
wards. The hospital’s bed manager, unaware of our
study, designated the patients to their wards.
Whether at the ED or directly at the wards, a staff
physician examined all patients on arrival, documenting
presenting complaint, past medical history, drug history
and examination findings. A nurse also assessed all
patients when arriving at the wards. This included stan-
dardised estimates of the risk of falls and pressure sores,
using the Downton Fall Risk Index and the Modified
Norton Scale, respectively [23,24]. These procedures
were done according to hospital policy.
Patients
Eligible patients were 60 years or older, residing in the
city of Malmö and not living in a nursing home. Occa-
sionally, eligible patients were not available to enter the
study, e.g. if patients were put in isolation due to noro-
virus infection.
Study personnel approached eligible and available
patients on the first or second day of their stay to deter-
mine appropriateness for cognitive testing. For example,
patients with terminal disease or severe aphasia were
considered inappropriate. Patients were considered in-
appropriate at admission if a possibly reversible condi-
tion was present, such as severe delirium (incoherent
speech, inability to focus attention) and/or abnormal
laboratory values (Haemoglobin < 100 g/L, temperaturev
> 38°C, C-Reactive Protein > 50 mg/L, abnormal electro-
lytes). These patients were assessed continuously and, if
the condition resolved, they were subsequently included.
Eligible, available and appropriate patients were
approached regarding consent. All included patients
gave their written informed consent. If cognitive testsdisclosed significant cognitive impairment, written con-
sent from an informant was collected as well. This pro-
cedure was approved by the regional ethics committee
at Lund University.Measurements
Three experienced research assistants (two certified
occupational therapists and one registered nurse) carried
out the measurements at the ward, in a private and calm
environment, between 8 am and 4 pm.Interviews and comorbidity
Interviews were held with patients concerning living
situation, family, education and access to home care.
Presenting complaints noted in the charts on admission
were recorded. Past medical history was extracted from
the hospital’s charts, all conditions noted during the
current or three preceding admissions were recorded.
Frequent conditions were classified as absent/present.
The list of current medications in the medical records
was examined on admission and the cumulative number
of drugs was noted. We used Charlson comorbidity index
to obtain a standardised estimate of comorbidity [25].Cognitive tests
The MMSE, (Mini-Mental State Examination) and the
CDT (Clock-Drawing Test) were employed [26,27]. The
MMSE is scored from 0–30, with 0 points representing
maximum cognitive impairment. As a cut-off, ≤ 23
points was used. In the CDT, the patients were asked to
draw a clock on a sheet of paper and add the hands of
the clock showing ”ten past eleven”. The CDT was
scored from 0 to 5 according to Shulman, where 0
points denote maximum cognitive impairment and 5
points a perfect clock [27]. Any scoring uncertainties
were discussed within the group until a consensus was
reached. As a cut-off, ≤ 3 points were used. Previous
studies have described a correlation between MMSE and
CDT scores, with a mean correlation coefficient of 0.61,
and that combining the tests gives higher diagnostic
accuracy for neurocognitive disorders [27]. The CDT is
also less affected by depression than the MMSE [28].QoL-AD
The Quality of Life in Alzheimer’s Disease (QoL-AD)
scale was employed [29]. The QoL-AD contains 13 items
(Physical health, Energy, Mood, Living situation, Mem-
ory, Family, Marriage, Friends, Self as a whole, Ability to
do chores around the house, Ability to do things for fun,
Money and Life as a whole). The items are rated from 1
to 4 where 1 represents poor, 2 fair, 3 good and 4 excel-
lent. The rating can be done by patients and/or proxies.
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SMCs were determined in two ways. Firstly, a direct yes/
no question was asked: ‘Do you think that your memory
has gotten worse lately?’ Secondly, the memory item of
the QoL-AD scale was used. This item was dichoto-
mised, with a score of 1–2 denoting subjective memory
complaints and 3–4 no impairment.
Informants
If available at the hospital, informants rated the patients’
quality of life with the QoL-AD scale. As for the
patients, the memory item was dichotomised and a score
of 1 or 2 denoted cognitive impairment. This was done
separately from the patients’ ratings.
Recognition by staff physicians
The staff physicians’ admission notes from the first day
were reviewed. Any notation of neurocognitive disorders
(dementia, delirium or MCI – mild cognitive impair-
ment) or current symptoms (disorientation, memory
impairment, confusion, irrational behaviour etc.) was
considered as recognition of cognitive impairment.
Recognition by staff nurses
The nurses’ admission notes were examined. The Down-
ton Fall Risk Index comprises a yes/no item entitled
”cognitive impairment” [23]. The Modified Norton Scale
includes the item ”mental condition”, that is scored from
1–4 (with 1 representing ”no contact”, 2 ”cannot answer
adequately”, 3 ”occasionally confused” and 4 ”fully
oriented”) [24]. Scores other than ”no cognitive impair-
ment” or ”fully oriented” on any of the scales was con-
sidered recognition of cognitive impairment.
Intervention status
The included patients were also taking part in a pro-
spective intervention study aiming to reduce hospital
readmissions. Interventions included a pharmacist’s med-
ication review and a changed discharge routine. For the
present study, only intervention status (control or inter-
vention) was recorded to rule out the possibility of this
confounding the results.
Statistical method
Patients were divided into three groups according to
their results on cognitive tests, with 0, 1 or 2 abnormal
test results, where patients with 1 abnormal result could
have a low score either on the MMSE or on the CDT.
All other baseline variables were compared between
the three groups. In the primary comparison, ANOVA
and chi-square tests were used where appropriate. In
secondary analyses we did pairwise comparisons be-
tween groups with Bonferroni correction for multiplecomparisons. The correlation between MMSE and CDT
scores was determined using Spearman’s rho.
Survival analysis
Bivariate Cox proportional hazards regressions were
done separately for demographic variables, comorbidity
variables and cognitive tests, adjusting for age and sex
where applicable. The ‘number of abnormal cognitive tests’
variable was dummy-coded to compare 1 abnormal test vs
0 and 2 abnormal tests vs 0. The assumption of propor-
tional hazards (that relative risk is not time-dependent)
was tested using log-log plots and time-interaction tests,
no violations of the assumption were found.
For the multivariable analysis a stepwise approach was
carried out, using a backwards method with p >0.051
as the threshold for removal. Starting the stepwise model
with all variables or only the ones with a bivariate
p value of <0.25 resulted in the same final model. Exclu-
sion of categorical variables with small cells (neurocogni-
tive disorder) did not affect the final model. Testing
for multiple collinearity revealed a moderate correlation
between ‘Charlson comorbidity index’ and ‘number of
drugs’ (Spearman’s rho, r = .46), exclusion of the latter
did not affect the final model. For each step our model
was controlled and fit the data adequately.
All calculations were done using the SPSS software
(SPSS version 19.0, SPSS inc. Chicago Illinois). A two-
sided p value of < 0.05 was considered significant.
Results
Patients
During the study period, 612 patients were admitted in
total. Of these, 98 were not eligible and 89 patients were
excluded because of hospital-related reasons. In 121
patients, cognitive testing was considered inappropriate.
At the point of consent, 69 patients declined participa-
tion. After consent, 35 patients were excluded, due to
issues occurring between consent and cognitive testing
(see Figure 1). Thus, the study population consisted of
200 patients. There were no differences between the
included patients, excluded patients or patients not giving
consent with regard to age (ANOVA, F (2, 609) = 1.49,
p=0.23) or sex (χ2 (2, N=612) = 3.88, p=0.14).
Results on cognitive tests
All 200 patients completed the MMSE and 198 patients
completed the CDT. In total, 55 patients (28%) had 0
abnormal test results, 68 (34%) had 1 abnormal result
(45 CDT and 23 MMSE) and 77 (39%) had abnormal
results on both the MMSE and the CDT.
Baseline measurements
Patients with 2 abnormal test results were older than
those with 0 abnormal tests. Patients with 1 .abnormal
612 patients
Under 60 (42)
Not living in Malmö (13)
Institutional living (43)
514 patients
Transfer to another department (22)
Prior enrolment (21)
Lost to early discharge (26)

















Figure 1 Patient flow showing exclusion criteria.
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with 0 abnormal test results. Regarding presenting com-
plaints, shortness of breath was the most prevalent,
accounting for nearly a third of admissions (32% in total).
Falls were more frequent in the group with 2 abnormal
cognitive tests than in the group with 1 abnormal test.
The mean scores on the MMSE and the CDT differed
significantly between all three groups. The results on the
CDT correlated moderately with the results on the
MMSE (Spearman’s rho, r(198) = .50, p < .001). Baseline
measurements are shown in Table 1.
Past medical history
Reviewing patients’ medical records showed no differ-
ences in prevalence of specific diagnoses between the
three groups. Neither were there any differences in mean
cumulative number of drugs in charts or in Charlson
comorbidity index. In total, 14 patients had a registered
ICD-10 diagnose of neurocognitive disorder (5 with
Alzheimer’s disease, 4 with unspecified dementia, 4 with
mild cognitive impairment and 1 with Parkinson’s dis-
ease with dementia). Of these 14 patients, 3 were found
in the group with 0 abnormal test, 2 in the group with 1
abnormal test and 9 in the group with 2 abnormal tests,
see Table 2.
Subjective memory complaints and recognition
When using the yes/no question, prevalence of SMCs
was similar in all three groups, with more than twothirds of patients experiencing SMCs. When using the
QoL-AD to measure SMCs, no significant differences
were found between groups. Informants (n = 141) classi-
fied 46/60 (77%) of the patients with 2 abnormal tests as
cognitively impaired. This was significantly more than in
the other groups, in which 9/37(24%) (0 abnormal tests)
and 17/44 (39%) (1 abnormal test) were classified as cog-
nitively impaired. Staff physicians recognised 44% of the
patients with 2 abnormal tests as cognitively impaired.
In the same group, staff nurses recognised 64%. Neither
physicians nor nurses recognised cognitive impairment
in the group of patients with 1 abnormal test to a larger
extent than in the group with 0 abnormal tests (Table 3).
Survival analysis
After 12 months, 63 patients (32%) in total were
deceased with a median survival of 96 days (interquartile
range 32–222). In the group with 0 abnormal tests, 8/55
(14%) were deceased, compared to 25/68 (37%) in the
group with 1 abnormal test and 30/77(39%) in the group
with 2 abnormal tests.
In bivariate Cox proportional hazards analysis four
variables were significant predictors of mortality; home
care, abnormal cognitive tests, heart failure and Charl-
son comorbidity index. The stepwise selection procedure
resulted in a final, multivariable model in which male
sex, home care, abnormal cognitive tests, and higher
Charlson comorbidity scores predicted mortality. The
hazard ratios (95% CI) of cognitive tests were similar for
1 and 2 abnormal tests vs 0, with 2.86 (1.28-6.39) and
3.39 (1.54-7.45), respectively, see Table 4. Kaplan-Meier
estimates of survival with the number of cognitive tests
as independent variable are shown in Figure 2.
Discussion
In this study we used two cognitive tests to show that
cognitive impairment was common in medical inpati-
ents, with 73% of patients having at least one abnormal
test result during hospitalisation. By using a multivari-
able Cox proportional hazards model, we showed that
cognitive impairment was associated with a three-fold
increase in 12-month mortality.
We divided the patients into three groups according to
their results on cognitive tests (with 0, 1 and 2 abnormal
tests). Demographic data, presenting complaints and
comorbidity showed only subtle differences between the
three groups. In terms of recognition, the hospital staff
did not recognise cognitive impairment in the group
with 1 abnormal test any more than in the group with-
out impairment. This is alarming, as the increase in
mortality risk of this group was substantial and similar
to that of the group with 2 abnormal tests. To improve
detection of cognitive impairment, our study suggests
that subjective memory complaints are too unspecific to
Table 1 Baseline characteristics





Age, mean(SD) 80.6(8.8) 83.1(8.5) 85.8(6.6) F(2, 197) = 7.45 0.001 b
Male sex 46% 30% 31% χ2(2, N= 200) = 3.64 0.16 -
Living alone 54% 78% 68% χ2(2, N= 200) = 6.63 0.04 a
Home care 44% 61% 62% χ2(2, N= 200) = 4.51 0.11 -
Education ≤8 years 46% 61% 54% χ2(2, N= 188) = 2.45 0.29 -
In intervention 50% 53% 47% χ2(2, N= 200) = 0.56 0.76 -
Presenting complaint
Shortness of breath 37% 33% 26% χ2(2, N= 200) = 2.25 0.33 -
Fall 9% 3% 17% χ2(2, N= 200) = 7.87 0.02 c
Chest pain 9% 9% 8% χ2(2, N= 200) = 0.08 0.96 -
Infection 15% 9% 4% χ2(2, N= 200) = 4.69 0.10 -
General condition 3% 16% 9% χ2(2, N= 200) = 6.61 0.04 a
Pain 7% 2% 7% FET(0vs1) N =123 0.17† -
Neurological symptoms 2% 10% 5% FET(0vs1) N =123 0.07† -
Psychiatric 0% 3% 9% FET(0vs2) N =132 0.04† -
Laboratory value 9% 6% 5% FET(0vs2) N =132 0.49† -
Lower extremity symptoms 6% 7% 4% FET(1vs2) N =145 0.48† -
Other 2% 2% 7% FET(1vs2) N =145 0.21† -
MMSE, mean(SD) 26.5(2.0) 24.3(2.5) 18.9(3.2) F(2, 197) = 143.62 (<0.001) †† a, b, c
CDT, mean(SD) 4.7(0.5) 3.4(1.1) 2.4(0.9) F(2, 195) = 109.62 (<0.001) †† a, b, c
Baseline characteristics of the groups with 0, 1 and 2 abnormal cognitive tests.
* Significant differences (p < 0.05) after Bonferroni correction:
a = between 0 vs 1 abnormal cognitive test.
b = between 0 vs 2 abnormal cognitive tests.
c = between 1 vs 2 abnormal cognitive tests.
†= Fischer’s exact test (FET) was used due to expected counts < 5. All three pairs (0vs1, 0vs2 and 1vs2) were compared, the comparisons with the lowest p values
are displayed.
††= The p values of cognitive tests are in brackets as they were the criteria for the division.
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sidered as valuable assets.
Our regression model did not retain variables that one
would expect to be significant predictors of mortality,
such as age or certain comorbidities, e.g. cancer. Regard-
ing age, this could be due to the designation of patients
to different departments at the hospital. At general
internal medicine wards, patients tended to be either
very old or slightly younger but with multiple comorbid-
ities, for example, a 65-year old with a heart attack
would typically be transferred from the ER to the
cardiology department but a 65-year old with diabetes,
hepatic failure, obesity, a neurologic disease and an
infection would more likely be transferred to a general
internal medicine ward. This selection could have
affected the impact of age on mortality in our study
population. Regarding comorbidities, these were coded
merely as absent/present, there was no severity ranking
or temporal perspective. Therefore, a patient who hadhad surgery 30 years ago for cancer of the colon was not
distinguished from a patient with present metastatic
disease. This is of course not a proper representation of
the clinical situation. However, the inclusion of Charlson
comorbidity index, a very stable and highly significant
comorbidity variable, in our model did not affect the
finding that cognitive impairment independently pre-
dicted mortality.
Studying nurses’ and physicians’ recognition at admis-
sion only may seem unfair to regular staff, as impair-
ment could have been discovered later on. However, for
ethical reasons, regular staff was informed promptly
when cognitive impairment was disclosed in a patient,
thus prohibiting studies of the staff ’s recognition further
along the admission. Changes in cognition could have
occurred between admission and administration of
cognitive tests, for example delirium resolving quickly or
incident delirium occurring between admissions and
testing. However, our cognitive tests were performed
Table 2 Past medical history




n= 55 n=68 n= 77
Ischemic heart disease 43% 34% 27% χ2(2, N= 200) = 3.05 0.22 -
Arrhythmia 39% 37% 30% χ2(2, N= 200) = 1.45 0.49 -
Heart failure 24% 30% 29% χ2(2, N= 200) = 0.81 0.67 -
Hypertension 47% 52% 47% χ2(2, N= 200) = 0.37 0.83 -
COPD 26% 19% 16% χ2(2, N= 200) = 2.00 0.37 -
Gastrointestinal disease 22% 18% 13% χ2(2, N= 200) = 1.80 0.41 -
Stroke/TIA 19% 21% 21% χ2(2, N= 200) = 0.16 0.92 -
Diabetes 22% 29% 18% χ2(2, N= 200) = 2.63 0.27 -
Cancer, nonskin 31% 30% 25% χ2(2, N= 200) = 0.72 0.70 -
Neurocognitive disorder 6% 4% 12% χ2(2, N= 200) = 3.21 0.22 -
Drugs in chart, mean(SD) 7.1(3.8) 7.6(4.0) 6.6(3.7) F(2, 197) = 1.20 0.30 -
Charlson comorbidity index, mean(SD) 2.3(1.7) 2.4(1.4) 2.1(1.5) F(2, 197) = 0.77 0.47 -
Past medical history of the three groups. TIA = transient ischemic attack. COPD= chronic obstructive pulmonary disorder.
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and patients were generally in a better state when tested
than upon admission. This indicates that changes of cog-
nition were likely to have been to the better, thus favour-
ing the staff ’s recognition on admission. The physicians
and the nurses were aware of the study and it is likely
that they were more vigilant towards cognitive symp-
toms than in regular conditions. Furthermore, we used
the most generous cut-offs possible to represent recogni-
tion. Taken together, it is unlikely that the recognition
rates by hospital staff have been underrated.
Representativity also needs to be addressed, as many
patients were not included. Patients excluded for
hospital-related reasons (with unknown cognitive status)
were fewer (n = 89) than patients excluded due to
disease-related conditions (n =121). The latter could be
assumed more cognitively impaired, given the exclusion




Subjective memory complaints yes/no 67% 7
Subjective memory complaints QoL-AD 48% 5
Cognitive impairment recognised by informant QoL-AD 24% 3
Cognitive impairment recognised by staff physician 9% 1
Cognitive impairment recognised by staff nurse 15% 1
Recognition of cognitive impairment.
* Significant differences (p < 0.05) after Bonferroni correction:
a = between 0 vs 1 abnormal cognitive test.
b = between 0 vs 2 abnormal cognitive tests.
c = between 1 vs 2 abnormal cognitive tests.
QoL-AD =Quality of life in Alzheimer’s disease.This would give a bias towards including the healthier
part of the population. This notion is also supported by
the fact that all included patients managed to fulfil the
interview and the MMSE. Thus, it is unlikely that the
prevalence of cognitive impairment is overrated.
We did not aim to diagnose dementia or delirium but
rather to study cognitive impairment in a broader sense
including its recognition and consequences in terms of
mortality. To some extent, we tried to exclude patients
with delirium but most likely patients fulfilling delirium
criteria were included in the study. However, our findings
imply that acknowledging cognitive impairment is import-
ant in medical inpatients regardless of its duration.
The main strengths of our study are its simplicity and
the possibility to apply the findings in a clinical setting.
We used two widely employed cognitive tests, taking
approximately 15 minutes to administer. These were




= 68 n= 77
3% 65% χ2(2, N= 200) = 1.45 0.48 -
5% 59% χ2(2, N= 200) = 1.74 0.42 -
9% 77% χ2(2, N= 141) = 29.05 <0.001 b
2% 44% χ2(2, N= 200) = 29.84 <0.001 b, c






















Figure 2 Kaplan-Meier estimates of 12-month survival for the three groups with 0, 1 and 2 abnormal cognitive test results.
Log rank χ2(df = 2, N= 200) = 9.7, p = 0.008.
Table 4 Cox proportional hazards
Bivariate models
HR (95% CI)
p value Multivariable model
HR (95% CI)
p value
Age (years) 1.03 (0.99-1.06) 0.11
Male sex 1.50 (0.91-2.47) 0.11 1.75 (1.02-2.93) 0.03
Living alone 1.12 (0.63-1.98) 0.70
Home care 1.96 (1.10-3.47) 0.02 1.82 (1.05-3.14) 0.03
Intervention status (0 = control, 1 = interv.) 1.03 (0.62-1.69) 0.92
Education≤ 8 years 1.03 (0.62-1.74) 0.90
Ischemic heart disease 1.07 (0.64-1.81) 0.79
Arrhythmia 1.21 (0.72-2.01) 0.47
Heart failure 1.98 (1.19-3.29) 0.01
Hypertension 0.96 (0.58-1.97) 0.87
COPD 1.18 (0.62-2.24) 0.62
Gastrointestinal disease 1.30 (0.71-2.40) 0.40
Stroke/TIA 0.96 (0.51-1.82) 0.91
Cancer, nonskin 1.44 (0.86-2.43) 0.17
Diabetes 1.04 (0.55-2.00) 0.90
Neurocognitive disorder 1.39 (0.60-3.23) 0.44
Drugs (total number) 1.05 (0.98-1.11) 0.15
Charlson index (points) 1.35 (1.16-1.58) <0.001 1.31 (1.12-1.54) 0.001
Cognitive tests
1 abnormal vs 0 2.98 (1.33-6.65) 0.008 2.86 (1.28-6.39) 0.01
2 abnormal vs 0 3.29 (1.47-7.45) 0.004 3.39 (1.54-7.45) 0.002
Cox proportional hazards. Bivariate models are adjusted for age and sex where applicable. All categorical variables are coded 0= no, 1 = yes unless
indicated otherwise.
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approach with 0, 1 or 2 abnormal test results to make a
crude estimation of cognitive impairment. Despite this
simple approach, our estimate of cognitive impairment
was a significant predictor of mortality in a clinical
material of 200 patients with multiple diseases. Fur-
thermore, we used simple questions and measures
already applied in hospital routine to study the recog-
nition of cognitive impairment from the patients’ per-
spective as well as from informants and different
healthcare professionals.
Conclusions
Our study highlights the need for improved detection of
cognitive impairment in hospitals, by confirming that
cognitive impairment is often underdiagnosed and asso-
ciated with an increased risk of mortality. Given the
high prevalence of cognitive impairment, a more active
approach to identify these patients is needed. Whether
mandatory cognitive tests are to be applied in all medical
inpatients should be a matter of discussion and further
study. It is however clear that undetected cognitive
impairment is far too common in medical inpatients and
recognition rates need to improve.
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